These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35193907)

  • 21. Primary and specialist care interaction and referral patterns for individuals with chronic kidney disease: a narrative review.
    Mutatiri C; Ratsch A; McGrail M; Venuthurupalli SK; Chennakesavan SK
    BMC Nephrol; 2024 Apr; 25(1):149. PubMed ID: 38689219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD.
    Hundemer GL; Tangri N; Sood MM; Ramsay T; Bugeja A; Brown PA; Clark EG; Biyani M; White CA; Akbari A
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1424-1432. PubMed ID: 32928746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study.
    Sullivan MK; Jani BD; Rutherford E; Welsh P; McConnachie A; Major RW; McAllister D; Nitsch D; Mair FS; Mark PB; Lees JS
    Br J Gen Pract; 2023 Feb; 73(727):e141-e147. PubMed ID: 36376072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.
    Tesfaye W; Krass I; Sud K; Johnson DW; Van C; Versace VL; McMorrow R; Fethney J; Mullan J; Tran A; Robson B; Vagholkar S; Kairaitis L; Gisev N; Fathima M; Tong V; Coric N; Castelino RL
    BMJ Open; 2023 Dec; 13(12):e079110. PubMed ID: 38128937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocol: Improving Access to Specialist Nephrology Care Among Rural/Remote Dwellers of Alberta: The Role of Electronic Consultation in Improving Care for Patients With Chronic Kidney Disease.
    Bello A; Zaidi D; Braam B; Courtney M; Glassford J; Jindal K; Klarenbach S; Kurzawa J; Osman M; Scott-Douglas N; Szigety S; Thompson S; Manns B; Hemmelgarn B; Tonelli M
    Can J Kidney Health Dis; 2019; 6():2054358119878715. PubMed ID: 31631888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease.
    Oliva-Damaso N; Delanaye P; Oliva-Damaso E; Payan J; Glassock RJ
    Clin Kidney J; 2022 Nov; 15(11):1996-2005. PubMed ID: 36325015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
    Fung E; Chang TI; Chertow GM; Thomas IC; Asch SM; Kurella Tamura M
    Am J Kidney Dis; 2017 Nov; 70(5):705-714. PubMed ID: 28811048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology.
    Venuthurupalli SK; Rolfe A; Fanning J; Cameron A; Hoy WE;
    Kidney Int Rep; 2018 Nov; 3(6):1336-1343. PubMed ID: 30450460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment decision-making and care among older adults with kidney failure: protocol for a multicentre, prospective observational cohort study with nested substudies and linked qualitative research (the Elderly Advanced CKD Programme).
    Siriwardana A; Gray NA; Makris A; Li CK; Yong K; Mehta Y; Ramos J; Di Tanna GL; Gianacas C; Addo IY; Roxburgh S; Naganathan V; Foote C; Gallagher M
    BMJ Open; 2022 Dec; 12(12):e066156. PubMed ID: 36581411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricaemia, gout and allopurinol in the CKD Queensland registry.
    Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
    J Nephrol; 2021 Jun; 34(3):753-762. PubMed ID: 33439469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.
    Smart NA; Dieberg G; Ladhani M; Titus T
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007333. PubMed ID: 24938824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION): a study protocol.
    Liang S; Wang WL; Zhu FL; Duan SW; Sun XF; Chen XM; Cai GY;
    BMJ Open; 2018 Feb; 8(2):e019457. PubMed ID: 29478020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy.
    Toal M; Fergie R; Quinn M; Hill C; O'Neill C; Maxwell AP
    Syst Rev; 2024 May; 13(1):122. PubMed ID: 38704598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
    Ali I; Donne RL; Kalra PA
    BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy.
    Gallagher H; Methven S; Casula A; Thomas N; Tomson CR; Caskey FJ; Rose T; Walters SJ; Kennedy D; Dawnay A; Cassidy M; Fluck R; Rayner HC; Nation M
    BMC Nephrol; 2017 Apr; 18(1):131. PubMed ID: 28399810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
    Foote C; Clayton PA; Johnson DW; Jardine M; Snelling P; Cass A
    Am J Kidney Dis; 2014 Sep; 64(3):359-66. PubMed ID: 24787762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimates of eskd risk and timely kidney replacement therapy education.
    Haggerty LE; Rifkin DE; Nguyen HA; Abdelmalek JA; Sweiss N; Miller LM; Potok OA
    BMC Nephrol; 2024 Sep; 25(1):300. PubMed ID: 39256683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving outpatient clinic experience: the future of chronic kidney disease care and associated multimorbidity.
    Al-Chalabi S; Alderson H; Garratt N; Green D; Kalra PA; Ritchie J; Santhirasekaran S; Poulikakos D; Sinha S
    BMJ Open Qual; 2023 Aug; 12(3):. PubMed ID: 37532458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating inequities in cardiovascular care and outcomes for Queensland Aboriginal and Torres Strait Islander people: protocol for a hospital-based retrospective cohort data linkage project.
    Kearns T; Diaz A; Whop LJ; Moore SP; Condon JR; Andrews RM; Katzenellenbogen JM; Matthews V; Wang W; Johnston T; Taylor C; Potts B; Kathage A; Suleman A; Stanley L; Mitchell L; Garvey G; Williamson D
    BMJ Open; 2021 Mar; 11(3):e043304. PubMed ID: 33741666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study.
    Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C;
    BMJ Open; 2019 Feb; 9(2):e024382. PubMed ID: 30796122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.